HMH(HMH)
HMH
No analyst ratings available
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $822M | $950M | $1.00B |
| Low | $819M | $939M | $1000M |
| High | $825M | $957M | $1.00B |
| EBITDA Avg | $284M | $328M | $346M |
| Low | $283M | $324M | $345M |
| High | $285M | $331M | $346M |
| EBIT Avg | $252M | $292M | $307M |
| Low | $251M | $288M | $307M |
| High | $253M | $294M | $307M |
| Net Income Avg | $63M | $99M | $108M |
| Low | $63M | $94M | $106M |
| High | $64M | $104M | $110M |
| EPS Avg | $1.44 | $2.26 | $2.47 |
| Low | $1.42 | $2.14 | $2.41 |
| High | $1.45 | $2.37 | $2.50 |
| Analysts (Rev / EPS) | 4 / 2 | 5 / 4 | 6 / 3 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $219M | $242M | $228M | $237M | $238M | $254M | $244M | $248M |
| Low | $217M | $240M | $227M | $235M | $236M | $252M | $243M | $246M |
| High | $220M | $243M | $229M | $238M | $239M | $255M | $245M | $249M |
| EBITDA Avg | $76M | $84M | $79M | $82M | $82M | $88M | $84M | $86M |
| Low | $75M | $83M | $78M | $81M | $82M | $87M | $84M | $85M |
| High | $76M | $84M | $79M | $82M | $83M | $88M | $85M | $86M |
| EBIT Avg | $67M | $74M | $70M | $73M | $73M | $78M | $75M | $76M |
| Low | $67M | $74M | $70M | $72M | $72M | $77M | $74M | $76M |
| High | $67M | $75M | $70M | $73M | $73M | $78M | $75M | $76M |
| Net Income Avg | $20M | $26M | $21M | $24M | $25M | $32M | — | — |
| Low | $18M | $26M | $21M | $23M | $25M | $31M | — | — |
| High | $23M | $26M | $21M | $24M | $25M | $32M | — | — |
| EPS Avg | $0.45 | $0.59 | $0.48 | $0.54 | $0.56 | $0.72 | — | — |
| Low | $0.40 | $0.58 | $0.47 | $0.53 | $0.56 | $0.72 | — | — |
| High | $0.51 | $0.59 | $0.48 | $0.54 | $0.57 | $0.73 | — | — |
| Analysts (Rev / EPS) | 5 / 4 | 2 / 2 | 2 / 2 | 2 / 1 | 2 / 1 | 2 / 2 | 1 / 3 | 1 / 2 |